🇺🇸 FDA
Patent

US 8685416

Compositions and methods for the treatment of cancer

granted A61KA61K47/549A61P

Quick answer

US patent 8685416 (Compositions and methods for the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K47/549, A61P, A61P35/00, A61P35/04